Intelligent Bio Solutions Inc. (INBS) vs Vivos Therapeutics, Inc. (VVOS)

Intelligent Bio Solutions Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Intelligent Bio Solutions Inc. is the larger, with a market value of $5.7M against $4.9M — 1.1× the size. Vivos Therapeutics, Inc. grew revenue faster over the last twelve months: 45.2% against 38.1%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −294.9%) and the higher return on invested capital (−592.7% vs −606.9%). Across the 17 metrics below, Vivos Therapeutics, Inc. leads on 11 and Intelligent Bio Solutions Inc. on 6.

Valuation

Metric INBS VVOS Medical Devices median
P/E n/m n/m 22.18
P/S 0.59 0.12 2.70
P/B 0.47 n/m 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.22 0.42 2.38
Earnings yield (530.59%) (1,357.14%) (8.22%)
Free cash flow yield (488.15%) (768.05%) (7.80%)

Profitability

Metric INBS VVOS Medical Devices median
Gross margin 48.64% 61.89% 56.01%
Operating margin (299.11%) (107.89%) (15.03%)
Net margin (294.91%) (121.79%) (20.40%)
Free cash flow margin (289.93%) (90.97%) (7.24%)
Return on equity (306.76%) 10,022.05% (15.32%)
Return on assets (123.13%) (101.46%) (19.72%)
Return on invested capital (606.86%) (592.70%) (10.33%)

Growth

Metric INBS VVOS Medical Devices median
Revenue growth (TTM) 38.09% 45.21% 8.80%
EPS growth (last fiscal year) 57.80% 6.76% —
Revenue growth, 5-year CAGR 16.31% 5.95% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INBS VVOS Medical Devices median
Debt to equity 0.00 (2.04) 0.07
Current ratio 1.44 0.21 2.50
Net debt to EBITDA 0.35 (0.37) 0.49

Dividend

Metric INBS VVOS Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric INBS VVOS Medical Devices median
Market cap 5.67m 4.94m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack